Zydus Cadila receives final approval for Voriconazole Tablets
From USFDA
Zydus Cadila has received final approval from the USFDA to market Voriconazole Tablets in strengths 50 mg and 200 mg. The drug will be produced at the group's formulations manufacturing facility at Baddi.Powered by Capital Market - Live News